Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of hnrnpa2b1 in cardiac fibroblasts

A fibroblast and heart technology, applied in the field of cell engineering and genetic engineering, can solve the problems of unclear specific mechanism of action and less research, and achieve good application value and the effect of promoting proliferation

Active Publication Date: 2022-04-01
JINAN CENTER HOSPITAL
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Nicotine, the main harmful component of tobacco, is an important risk factor for cardiovascular diseases, but there are few related studies, and its specific mechanism of action is still unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of hnrnpa2b1 in cardiac fibroblasts
  • Application of hnrnpa2b1 in cardiac fibroblasts
  • Application of hnrnpa2b1 in cardiac fibroblasts

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] 1. Pretreatment.

[0052] Experimental object: Cardiac fibroblasts from suckling rats of Wistar rats born 2-3 days old, provided by Beijing Weitong Lihua Company, and the medium used is DMEM high-glucose medium from Gibco, USA.

[0053] (1) Preparation before the experiment: ultra-clean bench ultraviolet sterilization for 30 minutes.

[0054](2) Take cardiac fibroblasts from suckling mice, digest them with type II collagenase, and perform differential adhesion in culture flasks to remove non-fibroblasts.

[0055] (3) discard the supernatant, re-add the culture medium, at 37°C, 5% CO 2 Incubate in the incubator for 24 hours.

[0056] 2. Inoculation and transfection of cardiac fibroblasts.

[0057] (1) When the confluence of cardiac fibroblasts reaches 90% under microscope, the medium is discarded, and the cells are washed twice with preheated PBS containing 1% double antibodies (penicillin and streptomycin).

[0058] (2) Add preheated 0.25% trypsin to the culture bot...

Embodiment 2

[0079] qRT-PCR experiments.

[0080] (1) Wash the adherent cells 2-3 times with cold PBS, tilt the cell culture dish, aspirate the PBS, add 1 mL of Trizol, let stand for 5 min, until the cells are completely lysed under the microscope, blow evenly with a pipette tip and remove Transfer to a 1.5 mL RNase-free centrifuge tube.

[0081] (2) Add 200 μL of precooling solution (Trizol interstitial fluid: chloroform ratio: 5:1) to each tube, shake vigorously for 15-30 s, place on ice for 5 min, and centrifuge at 12,000 rpm at 4°C for 15 min. The liquid is divided into three layers: the upper layer is colorless RNA, the middle layer is a white aqueous phase containing phenol-chloroform, and the lower layer is light red. Carefully pipette off the upper colorless liquid phase (avoid touching the middle phase). Transfer the upper liquid phase (about 300 μL) into a new 1.5 mL centrifuge tube, add an equal amount of isopropanol solution, gently shake up and down 10 times, and let stand o...

Embodiment 3

[0117] Drug Affinity Reaction Target Stability Test (DARTS for short).

[0118] The specific operation steps are as follows:

[0119] (1) Preparation of M-PER lysate (1mL).

[0120]Mix 10 μL of protease inhibitor cocktail, 10 μL of 200 mM phosphatase inhibitor, 50 μL of 1 M sodium fluoride, 100 μL of 100 mM β-glycerophosphate disodium, 100 μL of 50 mM sodium pyrophosphate, and 730 μL of M-PER to obtain M-PER lysate.

[0121] (2) Wash the cells twice with pre-cooled PBS, aspirate the PBS, add 500 μL of M-PER lysate to each large dish (2 / 3 dishes can be combined into one according to the cell density), scrape the cells with a cell scraper and move them to a 1.5 mL centrifuge tube , and incubated for 30 min at 4°C on a rotary shaker.

[0122] (3) Centrifuge at 13,000 rpm at 4°C for 10 min, take the supernatant, and measure the concentration. Store at -80°C or proceed to the next step.

[0123] (4) Two 1.5mL centrifuge tubes were each filled with 225μL protein, one tube was ad...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of cell engineering and genetic engineering, and relates to the application of HNRNPA2B1 in cardiac fibroblasts. The sequence of HNRNPA2B1 is SEQ ID No.1 in the nucleotide sequence list. The invention explores the key molecules and signaling pathways of nicotine-induced myocardial fibers, which is of great significance for clarifying the internal mechanism of myocardial fibrosis. The present invention verifies that after interfering with HNRNPA2B1, the expression of miR-125b-5p can be inhibited to achieve the purpose of anti-fibrosis, indicating that miR-125b-5p is an important functional target of HNRNPA2B1 in cardiac fibroblasts, and HNRNPA2B1 can pass through miR-125b ‑5p to regulate fibroblast function. It has good application value for studying the mechanism of nicotine-induced myocardial fibrosis.

Description

technical field [0001] The invention belongs to the technical field of cell engineering and genetic engineering, and relates to the application of HNRNPA2B1 in cardiac fibroblasts. Background technique [0002] Myocardial interstitial fibrosis is an important factor that induces arrhythmia and leads to heart failure. At present, the lack of effective clinical intervention strategies is a major problem that needs to be solved urgently. Myocardial fibrosis is an important pathological basis of heart failure, which is mainly manifested as increased activation of myocardial fibroblasts, abnormal deposition of collagen components, decreased myocardial elasticity, which affects cardiac output, and ultimately leads to cardiac insufficiency. If excessive myocardial fibrosis can be inhibited in time, it is expected to improve the overall function of the heart. Inhibiting excessive myocardial fibrosis is an important entry point for the prevention and treatment of heart failure and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6883C12N15/11
CPCC12Q1/6883C12Q2600/158C12Q2600/178
Inventor 苏国海李莹吴会会郑燕李悦妍陈嘉敏
Owner JINAN CENTER HOSPITAL